BioCardia Inc (BCDA)
NASDAQ:BCDA
Total Valuation
BioCardia has a market cap or net worth of $12.91M. The enterprise value is $4.87M.
Market Cap$12.91M
Enterprise Value$4.87M
Share Statistics
BioCardia has 10,940,372 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding10,940,372
Owned by Insiders18.15%
Owned by Institutions1.80%
Financial Efficiency
BioCardia’s return on equity (ROE) is -9.19 and return on invested capital (ROIC) is -581.73%.
Return on Equity (ROE)-9.19
Return on Assets (ROA)-2.41
Return on Invested Capital (ROIC)-581.73%
Return on Capital Employed (ROCE)-8.44
Revenue Per Employee0.00
Profits Per Employee-484.00K
Employee Count17
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of BioCardia is ―. BioCardia’s PEG ratio is 0.02.
PE Ratio―
PS Ratio0.00
PB Ratio9.31
Price to Fair Value9.31
Price to FCF-1.12
Price to Operating Cash Flow-1.71
PEG Ratio0.02
Income Statement
In the last 12 months, BioCardia had revenue of 0.00 and earned -8.23M in profits. Earnings per share was -1.23.
Revenue0.00
Gross Profit-505.00K
Operating Income-8.28M
Pretax Income-8.23M
Net Income-8.23M
EBITDA-7.77M
Earnings Per Share (EPS)-1.23
Cash Flow
In the last 12 months, operating cash flow was -7.44M and capital expenditures -7.00K, giving a free cash flow of -7.44M billion.
Operating Cash Flow-7.44M
Free Cash Flow-7.44M
Free Cash Flow per Share-0.68
Dividends & Yields
BioCardia pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.67
52-Week Price Change-55.97%
50-Day Moving Average1.25
200-Day Moving Average1.58
Relative Strength Index (RSI)44.99
Average Volume (3m)1.15M
Important Dates
BioCardia upcoming earnings date is May 13, 2026, After Close (Confirmed).
Last Earnings DateMar 24, 2026
Next Earnings DateMay 13, 2026
Ex-Dividend Date―
Financial Position
BioCardia as a current ratio of 1.12, with Debt / Equity ratio of 58.99%
Current Ratio1.12
Quick Ratio1.12
Debt to Market Cap0.06
Net Debt to EBITDA0.25
Interest Coverage Ratio0.00
Taxes
In the past 12 months, BioCardia has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
BioCardia EV to EBITDA ratio is -0.82, with an EV/FCF ratio of -0.86.
EV to Sales0.00
EV to EBITDA-0.82
EV to Free Cash Flow-0.86
EV to Operating Cash Flow-0.86
Balance Sheet
BioCardia has $2.50M in cash and marketable securities with $528.00K in debt, giving a net cash position of $1.97M billion.
Cash & Marketable Securities$2.50M
Total Debt$528.00K
Net Cash$1.97M
Net Cash Per Share$0.18
Tangible Book Value Per Share$0.13
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for BioCardia is $6.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$6.00
Price Target Upside417.24% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast-100.00%
EPS Growth Forecast58.50%